ArticleCancer immunology, immunotherapy : CII2025

Comparing neoadjuvant targeted therapy plus transarterial chemoembolization versus triple therapy including immunotherapy in hepatocellular carcinoma: a Chinese multicentre study.

Hao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.